Jeffrey B. Travers

12.3k total citations · 2 hit papers
240 papers, 9.0k citations indexed

About

Jeffrey B. Travers is a scholar working on Dermatology, Molecular Biology and Immunology. According to data from OpenAlex, Jeffrey B. Travers has authored 240 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Dermatology, 47 papers in Molecular Biology and 45 papers in Immunology. Recurrent topics in Jeffrey B. Travers's work include Dermatology and Skin Diseases (50 papers), Skin Protection and Aging (42 papers) and Neuroscience of respiration and sleep (24 papers). Jeffrey B. Travers is often cited by papers focused on Dermatology and Skin Diseases (50 papers), Skin Protection and Aging (42 papers) and Neuroscience of respiration and sleep (24 papers). Jeffrey B. Travers collaborates with scholars based in United States, Canada and Japan. Jeffrey B. Travers's co-authors include Ralph Norgren, Susan P. Travers, David V. Smith, Donald Y.M. Leung, Lisa A. DiNardo, Dan F. Spandau, Mark Boguniewicz, Bifeng Gao, Ichiro Nomura and Yong Pei and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Jeffrey B. Travers

233 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytokine Milieu of Atopic Dermatitis, as Compared to Psoriasis, Skin Prevents Induction of Innate Immune Response Genes

2003 583 citations Peck Y. Ong, Mark Boguniewicz et al. The Journal of Immunology profile →
Staphylococcus δ-toxin induces allergic skin disease by activating mast cells

2013 409 citations Jeffrey B. Travers et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey B. Travers United States	52	2.4k	1.9k	1.7k	1.5k	1.4k	240	9.0k
Xinzhong Dong United States	57	3.4k 1.4×	3.5k 1.8×	2.3k 1.4×	307 0.2×	551 0.4×	176	12.4k
Darlene A. Dartt United States	50	651 0.3×	1.8k 0.9×	673 0.4×	311 0.2×	420 0.3×	231	7.9k
Nigel W. Bunnett United States	87	1.9k 0.8×	9.3k 4.8×	3.1k 1.8×	1.1k 0.7×	1.0k 0.7×	358	29.5k
Martin Steinhoff United States	77	9.6k 3.9×	3.0k 1.6×	3.1k 1.8×	418 0.3×	369 0.3×	280	20.5k
Isaac M. Chiu United States	44	676 0.3×	2.2k 1.1×	2.3k 1.3×	183 0.1×	398 0.3×	80	8.9k
Michael Schemann Germany	54	333 0.1×	2.2k 1.1×	589 0.3×	631 0.4×	774 0.6×	221	9.9k
Eva M.J. Peters Germany	46	2.8k 1.1×	965 0.5×	837 0.5×	333 0.2×	255 0.2×	145	6.1k
Ari Waisman Germany	77	825 0.3×	6.0k 3.1×	10.7k 6.3×	762 0.5×	816 0.6×	286	22.1k
Thomas Scholzen Germany	34	821 0.3×	2.4k 1.2×	1.1k 0.6×	615 0.4×	552 0.4×	65	7.4k
Carlos Belmonte Spain	60	756 0.3×	1.9k 1.0×	168 0.1×	487 0.3×	503 0.4×	178	11.8k

Countries citing papers authored by Jeffrey B. Travers

Since Specialization

Citations

This map shows the geographic impact of Jeffrey B. Travers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey B. Travers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey B. Travers more than expected).

Fields of papers citing papers by Jeffrey B. Travers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey B. Travers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey B. Travers. The network helps show where Jeffrey B. Travers may publish in the future.

Co-authorship network of co-authors of Jeffrey B. Travers

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey B. Travers. A scholar is included among the top collaborators of Jeffrey B. Travers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey B. Travers. Jeffrey B. Travers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tong, Zhi‐Bin, Srilatha Sakamuru, Jeffrey B. Travers, et al.. (2025). MT1G activation in dopaminergic neurons identifies chelators and their relationships to cytotoxicity. SLAS DISCOVERY. 35. 100244–100244.

Shugar, Andrea, et al.. (2024). Mapping cutaneous field carcinogenesis of nonmelanoma skin cancer using mesoscopic imaging of pro‐inflammation cues. Experimental Dermatology. 33(4). e15076–e15076. 1 indexed citations

Margevicius, Seunghee, Joseph Rutter, Neil J. Korman, et al.. (2024). Circulating Monocytes Are Predictive and Responsive in Moderate-to-Severe Plaque Psoriasis Subjects Treated with Apremilast. Journal of Investigative Dermatology. 144(9). 1963–1974.e13. 1 indexed citations

Travers, Jeffrey B., et al.. (2023). Rosacea pathogenesis and therapeutics: current treatments and a look at future targets. Frontiers in Medicine. 10. 1292722–1292722. 10 indexed citations

Oyebanji, Oladayo A., Courtney E. W. Sulentic, Catherine M.T. Sherwin, et al.. (2023). Topical Photodynamic Therapy Generates Bioactive Microvesicle Particles: Evidence for a Pathway Involved in Immunosuppressive Effects. Journal of Investigative Dermatology. 143(7). 1279–1288.e9. 6 indexed citations

Dickerson, Tobin J., et al.. (2022). Insights into Lichen Planus Pigmentosus Inversus using Minimally Invasive Dermal Patch and Whole Transcriptome Analysis. PubMed. 10(1). 4 indexed citations

Travers, Jeffrey B., et al.. (2021). Age and insulin-like growth factor-1 impact PCNA monoubiquitination in UVB-irradiated human skin. Journal of Biological Chemistry. 296. 100570–100570. 4 indexed citations

Sattouf, Zafer, et al.. (2021). Vitamin D and Vitamin D Analogs as Adjuncts to Field Therapy Treatments for Actinic Keratoses: Current Research and Future Approaches. Journal of Skin Cancer. 2021. 1–12. 2 indexed citations

Travers, Jeffrey B., J. Mikhail Kellawan, Scott Guenthner, et al.. (2020). Inter- and Intra-Physician Variation in Quantifying Actinic Keratosis Skin Photodamage. PubMed. 8(2). 1–4. 1 indexed citations

10.

Weir, Nathan M., et al.. (2018). An aberrant reaction to Candida albicans antigen used for recalcitrant warts successfully treated with oral prednisone. JAAD Case Reports. 4(3). 242–244. 6 indexed citations

11.

Loesch, Mathew, David Southern, Sunil S. Tholpady, et al.. (2016). Insulin‐like growth factor‐1 receptor regulates repair of ultraviolet B‐induced DNA damage in human keratinocytes in vivo. PMC. 1 indexed citations

12.

Sahu, Ravi P., Matheus Ferracini, & Jeffrey B. Travers. (2015). Systemic Chemotherapy Is Modulated by Platelet-Activating Factor-Receptor Agonists. PMC. 1 indexed citations

13.

Sahu, Ravi P., Kathleen A. Harrison, Matheus Ferracini, et al.. (2014). Chemotherapeutic Agents Subvert Tumor Immunity by Generating Agonists of Platelet-Activating Factor. Cancer Research. 74(23). 7069–7078. 36 indexed citations

14.

Travers, Jeffrey B.. (2014). Toxic interaction between Th2 cytokines and Staphylococcus aureus in atopic dermatitis. PMC.

15.

Sahu, Ravi P., et al.. (2014). Topical Application of a Platelet Activating Factor Receptor Agonist Suppresses Phorbol Ester-Induced Acute and Chronic Inflammation and Has Cancer Chemopreventive Activity in Mouse Skin. Publisher. 2 indexed citations

16.

Travers, Jeffrey B., et al.. (2012). Hydrofluoric Acid Exposure: A Case Report and Review on the Clinical Presentation and Management. Dermatitis. 23(5). 231–236. 17 indexed citations

17.

Yang, Feng‐Chun, Chen Shi, Xiaohong Li, et al.. (2006). Nf1+/− mast cells induce neurofibroma like phenotypes through secreted TGF-β signaling. Human Molecular Genetics. 15(16). 2421–2437. 123 indexed citations

18.

Ong, Peck Y., Qutayba Hamid, Jeffrey B. Travers, et al.. (2002). Decreased IL-15 May Contribute to Elevated IgE and Acute Inflammation in Atopic Dermatitis. The Journal of Immunology. 168(1). 505–510. 33 indexed citations

19.

Leung, Chi-Sing, et al.. (1998). The role of superantigens in human diseases: therapeutic implications for the treatment of skin diseases. British Journal of Dermatology. 139. 17–29. 69 indexed citations

20.

Leung, Donald Y.M., Jeffrey B. Travers, Ralph Giorno, et al.. (1995). Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis.. Journal of Clinical Investigation. 96(5). 2106–2112. 225 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact